GLC determination of plasma concentrations of phenprocoumon.
A GLC method for the quantitative estimation of phenprocoumon from plasma is described. Plasma containing phenprocoumon, to which a known amount of phenytoin is added as the internal standard, is acidified and extracted with ethylene dichloride. The drug and the internal standard are then back-extracted into alkali, which is acidified and reextracted with ethylene dichloride. The organic extract is evaporated, and the evaporated residue is mixed with 50 mul of trimethylanilinium hydroxide in methanol. Aliquots (1-2 mul) are injected into a gas chromatography equipped with a flame-ionization detector in which the injection port is held at 325 degrees. The methyl derivatives of phenprocoumon and the internal standard give sharp, well-separated, symmetrical peaks. The method is of sufficient sensitivity to determine 0.125 mug/ml of the drug in plasma with a coefficient of variation of 7%.
D000477:Alkylating Agents; D000814:Aniline Compounds; D000818:Animals; D002849:Chromatography, Gas; D003374:Coumarins / Q000097:blood*; D004285:Dogs; D004355:Drug Stability; D006801:Humans; D066298:In Vitro Techniques; D008722:Methods; D008745:Methylation; D010644:Phenprocoumon / Q000031:analogs & derivatives / Q000097:blood*; D010672:Phenytoin / Q000097:blood; D013997:Time Factors
D000477:Alkylating Agents; D000814:Aniline Compounds; D003374:Coumarins; D010672:Phenytoin; D010644:Phenprocoumon